Stay updated on Sotorasib in Stage IV NSCLC: First-line Clinical Trial
Sign up to get notified when there's something new on the Sotorasib in Stage IV NSCLC: First-line Clinical Trial page.

Latest updates to the Sotorasib in Stage IV NSCLC: First-line Clinical Trial page
- CheckyesterdayChange DetectedThe revision/version indicator for this page updated from **v3.5.2** to **v3.5.3**, reflecting a small technical release with no substantive change to the clinical trial information shown.SummaryDifference0.1%

- Check8 days agoChange DetectedNew content sections were added to the record, including Adverse Events, Outcome Measures (Results), Baseline Characteristics, and Participant Flow, along with related document sections and status indicators. The entry shows a revision to v3.5.2 and notes that the quality control review has not concluded.SummaryDifference1%

- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedThe history shows the status changed from 'No Results Posted' to 'Results Submitted', indicating that results have been submitted but are not yet posted.SummaryDifference0.1%

- Check37 days agoChange DetectedAdded revision v3.5.0 to the history and removed revision v3.4.3.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check72 days agoChange DetectedNew revision entry v3.4.2 appears in the history, replacing the previous v3.4.1. No study data, descriptions, or outcomes are affected by this change.SummaryDifference0.1%

Stay in the know with updates to Sotorasib in Stage IV NSCLC: First-line Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotorasib in Stage IV NSCLC: First-line Clinical Trial page.